Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19

Laser treatment of Neuropathic Pain after COVID-19

Authors

  • Fernanda Cruz Gomes São Leopoldo Mandic, Departamento de Odontopediatria, Campinas, SP, Brazil
  • Christian Naurath Instituto Nacional do Câncer, Rio de Janeiro, RJ, Brazil
  • Luciane Hiramatsu Azevedo USP
  • Denise Maria Zezell Instituto de Pesquisas Energéticas e Nucleares, Centro de Lasers e Aplicações, São Paulo, SP, Brazil.

DOI:

https://doi.org/10.4322/bds.2021.e2962

Abstract

Objective: The purpose of this short communication is to show that although photobiomodulation in the
treatment of neurophathic oral pain after COVID-19 contagion could be an option, photobiomodulation is not
a new technique. PBMT was used with different protocols and pain was assessed using VAS (visual analogue
scale - 0 until 10) before and after the consultation. Results: Evolution of VAS during the sessions showed a
decrease in painful symptomatology as treatment was performed. Conclusion: Based on the results obtained in
the present case report, we concluded that PBMT with the parameters used in this clinical case was an effective,
noninvasive and a new option of treatment for neuralgia resulting from COVID-19.
KEYWORDS
Laser; Photobiomodulation therapy; COVID-19; Oral neuralgia.

Downloads

Download data is not yet available.

Downloads

Published

2021-12-17

How to Cite

1.
Gomes FC, Naurath C, Hiramatsu Azevedo L, Zezell DM. Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19: Laser treatment of Neuropathic Pain after COVID-19. BDS [Internet]. 2021 Dec. 17 [cited 2025 Aug. 21];24(4 Suppl). Available from: https://ojs.ict.unesp.br/index.php/cob/article/view/2962

Issue

Vol. 24 No. 4 Suppl (2021): Oct - Dec / 2021 SUPPL

Section

Case Report or Clinical Technique

License

Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.

=================

COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
 (PDF)

For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.

Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.

This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.

Most read articles by the same author(s)